Skip to main content
TipRanks
Go Ultimate75% OFF

Richard Baron Insider Profile

4 Followers

Richard Baron, Director at Immunome, holds 2.34K shares in Immunome (Ticker: IMNM), holds 15.96K shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 0.00 shares in Globus Medical (Ticker: GMED).

Richard Baron's Trading History

IMNM
Immunome
Aug 20, 2021DirectorUninformative Buy26.66K$43.70K
ZYNE
Zynerba Pharmaceuticals
Sep 15, 2015―Informative Buy63.51K$20.74K
GMED
Globus Medical
May 06, 2014Senior VPInformative Sell735.60K$0.00

You May Also Like

Richard Baron insider profile FAQ

What is the percentage of profitable transactions made by Richard Baron?
The percentage of profitable transactions made by Richard Baron is 0%.
What is the average return per transaction made by Richard Baron?
The average return per transaction made by Richard Baron is -26.40%.
What stocks does Richard Baron hold?
Richard Baron holds: IMNM, ZYNE, GMED stocks.
What was Richard Baron’s latest transaction?
Richard Baron’s latest transaction was an Uninformative Buy of $26.66K.
What was Richard Baron's most profitable transaction?
Richard Baron’s most profitable transaction was an Informative Sell of GMED stock on May 6, 2014. The return on the trade was -2.00%.
What is Richard Baron's role in Immunome?
Richard Baron's role in Immunome is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.